[Diabetic neuropathy: treatment trial with an aldose reductase inhibitor (Sorbinil)].
D000328:Adult; D000449:Aldehyde Reductase / Q000037:antagonists & inhibitors*; D001786:Blood Glucose / Q000378:metabolism; D003922:Diabetes Mellitus, Type 1 / Q000378:metabolism; D003929:Diabetic Neuropathies / Q000188:drug therapy*; D004311:Double-Blind Method; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D048289:Imidazolidines; D008875:Middle Aged; D009431:Neural Conduction / Q000187:drug effects; D011897:Random Allocation; D013401:Sugar Alcohol Dehydrogenases / Q000037:antagonists & inhibitors*
D001786:Blood Glucose; D007093:Imidazoles; D048289:Imidazolidines; D013401:Sugar Alcohol Dehydrogenases; D000449:Aldehyde Reductase; C026411:sorbinil
Diabetisk neuropati: Behandlingsforsøg med en aldosereduktasehaemmer (Sorbinil).